against radical-mediated toxicity and free radical-induced damage (8). According to Flora Iranica, Ilex spinigera and Gleditsia caspica are plants native to the forests of northern Iran, particularly in Guilan, Golestan, Mazandaran and Azerbaijan Provinces (9). These two plants have numerous antioxidant, biological and therapeutic properties (10, 11). The present study investigates effects of I. spinigera and G. caspica extracts on hemolysis induced by aspirin, phenacetin and phenylhydrazine hydrochloride in G6PD-deficient human erythrocytes.
MATERIALS AND METHODS
Leaves of I. spinigera and G. caspica were collected from Mazandaran forests. The specimens of I. spinigera (voucher Nr.4034) and G. caspica (voucher Nr. 5502) were obtained from the Herbarium of University of Mazandaran. The powdered plants samples (20 grams) were extracted using a method described in our previous work (10). Total phenolic and flavonoid content of each extract were assessed using the FolinCiocalteu phenol and aluminum chloride colorimetric methods (12, 13). All chemicals used in the study were of analytical grade and purchased from Fluka, Sigma and Merck Co. All kits were obtained from Kimia Pajouhan Co., Iran. We randomly collected 315 blood samples from men in Babolsar. G6PD deficiency was screened in the samples using the fluorescent spot test (Kimia Pajouhan kits) (14). To determine the concentration of the drugs that could produce approximately 50% hemolysis in the G6PD-deficient erythrocytes, suspension aliquots were incubated with varying amounts of the drugs (0 to 4 mM) (15) . The percentage of hemolysis was calculated by dividing the absorbance reading (at 540 nm) from the experimental tubes by the mean value of complete hemolysis induced by distilled water multiplied by 100. Data were expressed as means ± standard deviation. All measurements were replicated three times. Half-maximal inhibitory concentration (IC 50 ) values were calculated via linear regression analysis. One-way analysis of variance (ANOVA) and Tukey's post-test were carried out for comparison of data. P-values less than 0.05 were considered statistically significant.
INTRODUCTION
Glucose-6-phosphate dehydrogenase (G6PD, EC: 1.1.1.49) is an important and highly conserved enzyme in the pentose phosphate metabolic pathway (1) . It catalyzes the simultaneous oxidation of glucose-6-phosphate to 6-phosphogluconate and reduction of NADP + to NADPH. This process leads to the conversion of oxidized glutathione to reduced glutathione (GSH), which protects human cells from oxidative damage (2) . A free radical is any molecular species capable of independent existence that contains one or more unpaired electrons. The oxygen radicals and related species, singlet oxygen, superoxide radicals and hydrogen peroxide are known as reactive oxygen species (ROS). Imbalance between ROS and antioxidants causes oxidative stress, which can lead to cell damage (3) . Oxidative stress could be due to increased ROS production, and toxicity caused by drugs (e.g. trimethoprim, sulfamethoxazole, dapsone, primaquine, etc.), acute infection (acute hepatitis A, hepatitis B, cytomegalovirus, pneumonia, etc.), or some foods (fava beans) can also cause G6PD deficiency-related hemolysis (4). Primaquine is the only drug currently licensed for the radical treatment of Plasmodium vivax malaria. However, it can cause severe hemolysis in individuals with G6PD deficiency, a common genetic disorder that is positively associated with P. vivax incidence. G6PD deficiency is largely asymptomatic until individuals are exposed to external sources of oxidative stress, including certain nutrients and drugs, but most notably fava beans (5). GSH is a major antioxidant that protects cells against oxidative damage (6) . A proposed mechanism for the lack of resistance of G6PD-deficient RBCs to oxidative stress is shown in figure 1 . The interaction of drugs with RBCs leads to hydrogen peroxide production, either directly or through ROS. GSH can remove the produced hydrogen peroxide in the presence of glutathione peroxidase. The produced oxidized glutathione will be reduced to regenerate GSH through the activity of glutathione reductase. Then, continuous reduction of NADP to NADPH relies on the G6PD activity (7). Antioxidants, flavonoids and phenolic compounds act as a major defense system 22/ Protective Effect of Ilex. . .
(0.459±0.007 mg quercetin equivalents per gram of dried leaves). Our results revealed that the frequency of G6PD deficiency is 15% among males in Babolsar, Iran. Figures 2-4 show that G6PD-deficient and normal human erythrocytes undergo hemolysis when exposed to aspirin, phenylhydrazine hydrochloride and phenacetin.
RESULTS
The extraction yield and total phenolic and flavonoid content of the extracts are reported in table 1. The total phenolic content was higher in the methanol extract of G. caspica (0.123 ± 0.003 mg gallic acid equivalents per gram of dried leaves). Similarly, the total flavonoid content was higher in the G. caspica extract extract at a high dose (600 µg/ml) did not have any side effects on the RBCs when used alone. The inhibitory activity of the extract was compared with that of the positive control, glutathione (0.5 mM). In all cases except for phenylhydrazine hydrochloride, glutathione had significant inhibitory activity against the tested drugs (P<0.05).
The degree of hemolysis is dependent on concentration of the hemolytic agent present in the medium. The I. spinigera extract had no significant effect on the hemolysis induced by aspirin, phenacetin and phenylhydrazine hydrochloride in G6PD-deficient erythrocytes (P>0.05). However, the plant extract showed higher anti-hemolytic activity at higher concentrations ( Figure 5 ). The I. spinigera High concentrations of this extract had no side effect on the RBCs when used alone. The inhibitory activity of glutathione was significant against all tested drugs except for phenylhydrazine hydrochloride.
aspirin have been shown to be even greater in G6PD-deficient individuals (19) . Shahidi proved that a metabolic intermediate of acetylsalicylic acid inhibits G6PD in subjects with severe G6PD-deficiency (20) Phenylhydrazine increases generation of hydrogen peroxide when incubated with RBCs (19) . Incubation of normal and G6PD-deficient RBCs with phenylhydrazine induces a decrease in adenosine triphosphate level and a subsequent increase in adenosine diphosphate and adenosine monophosphate levels (21) . Phenylhydrazine reacts with oxyhemoglobin and generates hydrogen peroxide or equivalent free radicals, which in turn oxidize hemoglobin and other proteins (22) . Hemolytic anemia induced by phenacetin may be acute or chronic. The main features of phenacetininduced chronic hemolytic anemia are alteration of RBC morphology and permeability as well as formation of methemoglobin, sulfhemoglobin and Heinz bodies (23) . Since the G. caspica leaf extract has strong radical scavenging activity, it could act as a defense mechanism against phenacetin-induced hemolysis in G6PD-deficient erythrocytes. Erythrocytes have a high content of polyunsaturated lipids, which along with the rich oxygen supply and transition metals make them more susceptible to lipid peroxidation (24) . Any process that increases peroxidation in membrane lipids also increases erythrocyte fragility (25) . Although
The G. caspica extract showed antihemolytic activity in a dose-dependent manner ( Figure 6 ). This activity was significant only in the case of phenacetin-induced hemolysis (P< 0.05).
DISCUSSION
It is well established that the biological and therapeutic activities of a plant relies primarily on its contents (16) . In a previous study, we demonstrated that the G. caspica extract with a higher phenolic and flavonoid content than I. spinigera, could effectively protect G6PD-deficient erythrocytes against hemolysis induced by 2,2'-azobis(2-amidinopropane) dihydrochloride. In the present study, the G. caspica extract showed similar in vitro protective effects against phenacetin-induced hemolysis. While mechanisms of hemolysis induced by these substances are not clear, a common quality shared by most hemolytic agents is the ability to produce oxidative cell damage (17) . RBC loses its nucleus, ribosomes, mitochondria and other organelles during its development process. As a result, the mature circulating erythrocytes cannot replicate or synthesize protein, and have limited number of enzymatic reactions. G6PD-deficient erythrocytes do not have the adequate capacity to destroy peroxides hence cannot withstand hemolysis. Under oxidative stress, GSH depletion becomes quicker than GSH regeneration (18) . Most drugs that can induce hemolysis in G6PD-deficient erythrocytes possess oxidative properties. Although aspirin is classified as a mild hemolytic agent, it might cause severe hemolysis of erythrocytes even at small therapeutic doses. The hemolytic effects of the anti-hemolytic effect of the G. caspica extract might be due to its membranestabilizing effects as well as its free radical scavenging activity.
CONCLUSION
We demonstrated that the methanol extract of Gleditsia caspica has strong antioxidant and anti-hemolytic properties, and therefore can be used as a potential drug for subjects with G6PD deficiency. In addition, the extract has no side effects on erythrocytes. However, more studies are required to confirm these results.
